Pavinato Lisa, Baggiolini Arianna
Institute of Oncology Research (IOR), Bellinzona Institutes of Science (BIOS+), Bellinzona, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
Institute of Oncology Research (IOR), Bellinzona Institutes of Science (BIOS+), Bellinzona, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
Trends Cancer. 2025 Apr;11(4):276-285. doi: 10.1016/j.trecan.2025.01.002. Epub 2025 Jan 28.
Cancer development is driven by mutations, yet tumor-causing mutations only lead to tumor formation within specific cellular contexts. The reasons why certain mutations trigger malignant transformation in some contexts but not others remain often unclear. Both intrinsic and extrinsic factors play a key role in driving carcinogenesis by leading the cells toward a state of 'oncogenic competence'. This state is shaped by the transcriptional and epigenetic programs that define a specific cell in time and space. These programs arise from the interplay between genetic mutations, cellular lineage, differentiation state, and microenvironment. A deeper understanding of oncogenic competence is essential to uncover the mechanisms behind tumor initiation and, ultimately, advance the development of novel targeted therapies for cancer treatment and prevention.
癌症的发展是由突变驱动的,但致癌突变仅在特定的细胞环境中才会导致肿瘤形成。某些突变在某些环境中引发恶性转化而在其他环境中却不会的原因往往仍不明确。内在和外在因素在驱动致癌过程中都起着关键作用,它们会使细胞趋向于一种“致癌能力”状态。这种状态由在时间和空间上定义特定细胞的转录和表观遗传程序所塑造。这些程序源于基因突变、细胞谱系、分化状态和微环境之间的相互作用。深入了解致癌能力对于揭示肿瘤起始背后的机制至关重要,最终有助于推动新型癌症治疗和预防靶向疗法的发展。